OtherClinical Investigations (Human)
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
Journal of Nuclear Medicine December 2017, jnumed.117.203257; DOI: https://doi.org/10.2967/jnumed.117.203257
Jeremie Calais
UCLA, United States
Wolfgang P. Fendler
UCLA, United States
Ken Herrmann
UCLA, United States
Matthias Eiber
UCLA, United States
Francesco Ceci
UCLA, United States
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Dec 2017, jnumed.117.203257; DOI: 10.2967/jnumed.117.203257
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Dec 2017, jnumed.117.203257; DOI: 10.2967/jnumed.117.203257
Jump to section
Related Articles
Cited By...
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
- One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging
- Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
- Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
- Molecular Imaging of Prostate Cancer: Choosing the Right Agent